Start / The Hematologist / Pomalidomide a step on the path forward for treatment of hereditary hemorrhagic telangiectasia

The Hematologist

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

22 min • 23 juni 2025

In this episode, Contributing Editor Surbhi Shah, MBBS, MD, a clinician, researcher, and educator at Mayo Clinic in Phoenix, Arizona, talks with Keith McCrae, MD, director of classical hematology at the Taussig Cancer Institute and professor of molecular medicine at the Cleveland Clinic Lerner College of Medicine in Ohio. They discuss a recent paper co-authored by Dr. McCrae, “Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.” Support for this episode provided by Autolus.

Senaste avsnitt

More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia

28 juli | 23 min

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

23 juni | 22 min

Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

24 maj | 19 min

When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists

16 maj | 11 min

No Scientific Link Found Between Sickle Cell Trait and Sudden Death

28 april | 21 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00